Dermatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Dermatitis, including details on contact-, seborrheic-, atopic-, allergic-dermatitis, treatment.

Clinical and immunopathologic findings during treatment of recalcitrant atopic eczema with efalizumab.

Hassan AS, Kaelin U, Braathen LR, Yawalkar N

Department of Dermatology, University of Bern, Inselspital, Switzerland.

Treatment of widespread moderate to severe atopic eczema remains a challenge. The therapeutic efficacy and modifications of the immune response during treatment of atopic eczema with efalizumab are so far unknown. We hereby report the clinical findings and characterize the inflammatory infiltrate during treatment of severe recalcitrant atopic eczema with efalizumab.

Published 16 January 2007 in J Am Acad Dermatol, 56(2): 217-21.
Full-text of this article is available online (may require subscription).

© 2004-2008 Dermatitis Research Today. All Rights Reserved.